ICU Medical officer plans sale of 9,307 shares

Rhea-AI Filing Summary

ICU MEDICAL, INC. (ICUI) received a notice that officer Brian Michael Bonnell intends to sell common stock under Rule 144. The planned sale covers 9,307 shares of ICUI common stock through Morgan Stanley Smith Barney LLC on or after 08/31/2026, listed on NASDAQ.

The shares were acquired from the issuer upon vesting of Restricted Stock and Performance Shares originally granted on 08/16/2019, with vesting occurring between 08/16/2019 and 03/06/2023. The filing reports an aggregate market value of about $1,608,142.82 for the shares to be sold and indicates no ICUI shares sold by this person in the past three months.

Key Figures

Shares to be sold: 9,307 shares of common stock Aggregate market value: $1,608,142.82 Planned sale date: 08/31/2026 +2 more

5 metrics

Shares to be sold 9,307 shares of common stock Number of ICUI shares covered by the Rule 144 notice

Aggregate market value $1,608,142.82 Aggregate market value of 9,307 ICUI shares to be sold

Planned sale date 08/31/2026 Date associated with the planned NASDAQ sale of the shares

Acquisition grant date 08/16/2019 Grant date for Restricted Stock and Performance Shares that later vested

Vesting period end 03/06/2023 End of vesting period for the Restricted Stock and Performance Shares

Key Terms

Rule 144, Restricted Stock, Performance Shares, aggregate market value, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"acquired upon the vesting of Restricted Stock and Performance Shares"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"acquired upon the vesting of Restricted Stock and Performance Shares"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

aggregate market value financial

"9307 | 1608142.82 | 25007038 | 08/31/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Form 144 regulatory

"144: Filer Information Filer CIK"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for ICUI shareholders?

It discloses that officer Brian Michael Bonnell plans to sell 9,307 ICUI shares under Rule 144 through Morgan Stanley Smith Barney LLC, with an aggregate market value of about $1,608,142.82, based on the figures in the notice.

How many ICUI shares are covered by Brian Bonnell’s planned Rule 144 sale?

The notice covers 9,307 shares of ICU MEDICAL, INC. common stock to be sold under Rule 144, as listed in the securities information section.

When is the planned Rule 144 sale for ICUI shares expected to occur?

The Form 144 lists a planned sale date of 08/31/2026 for the 9,307 ICUI shares to be sold on NASDAQ through Morgan Stanley Smith Barney LLC.

What is the approximate market value of the ICUI shares to be sold under this Form 144?

The filing states an aggregate market value of $1,608,142.82 for the 9,307 ICUI shares covered by the planned Rule 144 sale.

How did Brian Bonnell acquire the ICUI shares being sold?

The shares were acquired from the issuer upon the vesting of Restricted Stock and Performance Shares, granted on 08/16/2019 and vesting between 08/16/2019 and 03/06/2023, as noted in the remarks.

Have there been any ICUI share sales by this insider in the past three months?

The Form 144 indicates no ICUI shares sold by this person in the past three months, as the section for securities sold during that period contains no transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 04:14 PM EDT Accepted by SEC EDGAR 08/31/2026 - 04:13 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001804831
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ICU MEDICAL, INC.
SEC File Number	001-34634
Address of Issuer	951 Calle Amanecer San Clemente CALIFORNIA 92673
Phone	(949) 366-2183
Name of Person for Whose Account the Securities are To Be Sold	BRIAN BONNELL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9307	1608142.82	25007038	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/16/2019	Performance Shares and Restricted Stock	ISSUER			9307	08/16/2019	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of Restricted Stock and Performance Shares during the period of 08/16/2019 through 03/06/2023
Date of Notice	08/31/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brian Michael Bonnell
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)